摘要
目的:探讨布地奈德+沙丁胺醇雾化吸入对新生儿肺炎治疗效果。方法:选择我院2013年7月-2015年7月新生儿肺炎患者72例。通过抽签随机分组。B2组(对照组36例):选择浓度为0.9%的氯化钠注射液实施雾化吸入;B1组(观察组36例):选择布地奈德+沙丁胺醇实施雾化吸入。对比两组住院时间以及疾病症状改善程度。结果:临床治疗总有效率,B1组明显高于B2组(P〈0.05);在症状改善程度方面,B1组明显优于B2组(P〈0.05)。结论:针对新生儿肺炎,临床选择沙丁胺醇+布地奈德雾化吸入进行治疗,表现出较高安全性,凸显临床价值。
Objective: to study the selection method of salbutamol aerosol inhalation budesonide + in patients with neonatal pneumonia after completion for the clinical effect of treatment. Methods: from July 2013 -July 2015,72 patients with neonatal pneumonia. Through the draw method for randomized patients with neonatal pneumonia. B2 group(the control group 36 cases) : choose a concentration of0.9% sodium chloride injection for patients with aerosol inhalation; B1(observation group 36 cases) : select budesonide + salbutamol aerosol inhalation for patients. Compared two groups of patients with neonatal pneumonia in terms of length of hospital stay and disease symptoms improved degree show the difference. Results: all the clinical total effective rate in patients with neonatal pneumonia,B1 group is significantly higher than B2 children(P〈0.05); In terms of degree of symptoms improvement,B1 B2 is obviously better than the group patients(P 〈0.05). Conclusion: for patients with neonatal pneumonia,the clinical choice albuterol + budesonide aerosol inhalation method of treatment,show that the treatment of high security,highlighting the clinical value of treatment of patients with neonatal pneumonia.
出处
《北方药学》
2015年第11期70-71,共2页
Journal of North Pharmacy